Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial (vol 11, pg 503, 2012)

被引:0
|
作者
Easton, J. D.
Lopes, R. D.
Bahit, M. C.
机构
来源
LANCET NEUROLOGY | 2012年 / 11卷 / 12期
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:1021 / 1021
页数:1
相关论文
共 50 条
  • [1] Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial
    Easton, J. Donald
    Lopes, Renato D.
    Bahit, M. Cecilia
    Wojdyla, Daniel M.
    Granger, Christopher B.
    Wallentin, Lars
    Alings, Marco
    Goto, Shinya
    Lewis, Basil S.
    Rosenqvist, Marten
    Hanna, Michael
    Mohan, Puneet
    Alexander, John H.
    Diener, Hans-Christoph
    LANCET NEUROLOGY, 2012, 11 (06): : 503 - 511
  • [2] Dabigatran compared with warfarin in patients with atrial fibrillation and previous transient ischaemic attack or stroke: a subgroup analysis of the RE-LY trial
    Diener, Hans Chnstoph
    Connolly, Stuart J.
    Ezekowitz, Michael D.
    Wallentin, Lars
    Reilly, Paul A.
    Yang, Sean
    Xavier, Denis
    Di Pasquale, Giuseppe
    Yusuf, Salim
    LANCET NEUROLOGY, 2010, 9 (12): : 1157 - 1163
  • [3] Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF
    Hankey, Graeme J.
    Patel, Manesh R.
    Stevens, Susanna R.
    Becker, Richard C.
    Breithardt, Gunter
    Carolei, Antonio
    Diener, Hans-Christoph
    Donnan, Geoffrey A.
    Halperin, Jonathan L.
    Mahaffey, Kenneth W.
    Mas, Jean-Louis
    Massaro, Ayrton
    Norrving, Bo
    Nessel, Christopher C.
    Paolini, John F.
    Roine, Risto O.
    Singer, Daniel E.
    Wong, Lawrence
    Califf, Robert M.
    Fox, Keith A. A.
    Hacke, Werner
    LANCET NEUROLOGY, 2012, 11 (04): : 315 - 322
  • [4] Dabigatran compared with warfarin in patients with atrial fibrillation and previous transient ischaemic attack or stroke: a subgroup analysis of the RE-LY trial (vol 9, pg 1157, 2010)
    Diener, H. C.
    Connolly, S. J.
    Ezekowitz, M. D.
    LANCET NEUROLOGY, 2011, 10 (01): : 27 - 27
  • [5] Apixaban versus aspirin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a predefined subgroup analysis from AVERROES, a randomised trial
    Diener, Hans-Christoph
    Eikelboom, John
    Connolly, Stuart J.
    Joyner, Campbell D.
    Hart, Robert G.
    Lip, Gregory Y. H.
    O'Donnell, Martin
    Hohnloser, Stefan H.
    Hankey, GraemeJ
    Shestakovska, Olga
    Yusuf, Salim
    LANCET NEUROLOGY, 2012, 11 (03): : 225 - 231
  • [6] APIXABAN COMPARED WITH WARFARIN IN PATIENTS WITH DIABETES AND NONVALVULAR ATRIAL FIBRILLATION IN THE ARISTOTLE TRIAL
    Ezekowitz, Justin A.
    Lewis, Basil
    Lopes, Renato
    Wojdyla, Daniel
    McMurray, John
    Hanna, Michael
    Atar, Dan
    Bahit, Maria
    Keltai, Matyas
    Lopez-Sendon, Jose
    Pais, Prem
    Ruzyllo, Witold
    Wallentin, Lars
    Alexander, John
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (12) : A372 - A372
  • [8] Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Previous Stroke or Transient Ischemic Attack
    Coleman, Craig I.
    Peacock, W. Frank
    Bunz, Thomas J.
    Alberts, Mark J.
    STROKE, 2017, 48 (08) : 2142 - +
  • [9] Efficacy and Safety of Apixaban Compared with Warfarin for Stroke Prevention in Patients with Atrial Fibrillation from East Asia: A Subanalysis of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial
    Goto, Shinya
    Zhu, Jun
    Liu, Lisheng
    Oh, Byung-Hee
    Wojdyla, Daniel M.
    Aylward, Philip
    Bahit, M. Cecilia
    Gersh, Bernard J.
    Hanna, Michael
    Horowitz, John
    Lopes, Renato D.
    Wallentin, Lars
    Xavier, Denis
    Alexander, John H.
    AMERICAN HEART JOURNAL, 2014, 168 (03) : 303 - 309
  • [10] Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial
    Halvorsen, Sigrun
    Atar, Dan
    Yang, Hongqiu
    De Caterina, Raffaele
    Erol, Cetin
    Garcia, David
    Granger, Christopher B.
    Hanna, Michael
    Held, Claes
    Husted, Steen
    Hylek, Elaine M.
    Jansky, Petr
    Lopes, Renato D.
    Ruzyllo, Witold
    Thomas, Laine
    Wallentin, Lars
    EUROPEAN HEART JOURNAL, 2014, 35 (28) : 1864 - 1872